Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or jco.ascopubs.org/site/ifc. Gustavo dos Santos FernandesHonoraria: Roche, Amgen, Novartis Consulting or Advisory Role: Roche, Sandoz, Mundipharma Speakers' Bureau: Roche Travel, Accommodations, Expenses: Roche, Novartis, Amgen, Merck, BayerGilberto de Lima Lopes JrHonoraria: AstraZeneca, Genentech, Merck Serono, Merck Sharp & Dohme, Fresenius Kabi, Novartis, Bristol-Myers Squibb, Janssen-Cilag Consulting or Advisory Role: Pfizer, Bristol-Myers Squibb, Eli Lilly Research Funding: Eli Lilly, Pfizer, AstraZeneca, Merck Sharp & Dohme, Eisai Expert Testimony: Sanofi